Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 204

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

Open access
Greenhawt, Matthew, Abrams, Elissa M., Shaker, Marcus, Chu, Derek K., Khan, David, Akin, Cem, Alqurashi, Waleed, Arkwright, Peter, Baldwin, James L., Ben-Shoshan, Moshe, Bernstein, Jonathan, Bingemann, Theresa, Blumchen, Katharina, Byrne, Aideen, Bognanni, Antonio, Campbell, Dianne, Campbell, Ronna, Chagla, Zain, Chan, Edmond S., Chan, Jeffrey, Comberiati, Pasquale, Dribin, Timothy E., Ellis, Anne K., Fleischer, David M., Fox, Adam, Frischmeyer-Guerrerio, Pamela A., Gagnon, Remi, Grayson, Mitchell H., Horner, Caroline C., Hourihane, Jonathan, Katelaris, Constance H., Kim, Harold, Kelso, John M., Lang, David, Ledford, Dennis, Levin, Michael, Lieberman, Jay, Loh, Richard, Mack, Doug, Mazer, Bruce, Mosnaim, Giselle, Munblit, Daniel, Mustafa, S. Shahzad, Nanda, Anil, Oppenheimer, John, Perrett, Kirsten P., Ramsey, Allison, Rank, Matthew, Robertson, Kara, Sheikh, Javed, Spergel, Jonathan M., Stukus, David, Tang, Mimi L.K., Tracy, James M., Turner, Paul J., Whalen-Browne, Anna, Wallace, Dana, Wang, Julie, Waserman, Susan, Witry, John K., Worm, Margitta, Vander Leek, Timothy K., Golden, David B.K. · 2021 · The Journal of Allergy and Clinical Immunology: In Practice

Abstract

Concerns for anaphylaxis may hamper severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunization efforts. We convened a multidisciplinary group of international experts in anaphylaxis composed of allergy, infectious disease, emergency medicine, and front-line clinicians to systematically develop recommendations regarding SARS-CoV-2 vaccine immediate allergic reactions. Medline, EMBASE, Web of Science, the World Health Organizstion (WHO) global coronavirus database, and the gray literature (inception, March 19, 2021) were systematically searched. Paired reviewers independently selected studies addressing anaphylaxis after SARS-CoV-2 vaccination, polyethylene glycol (PEG) and polysorbate allergy, and accuracy of allergy testing for SARS-CoV-2 vaccine allergy. Random effects models synthesized the data to inform recommendations based on the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE) approach, agreed upon using a modified Delphi panel. The incidence of SARS-CoV-2 vaccine anaphylaxis is 7.91 cases per million (n = 41,000,000 vaccinations; 95% confidence interval [95% CI] 4.02-15.59; 26 studies, moderate certainty), the incidence of 0.15 cases per million patient-years (95% CI 0.11-0.2), and the sensitivity for PEG skin testing is poor, although specificity is high (15 studies, very low certainty). We recommend vaccination over either no vaccination or performing SARS-CoV-2 vaccine/excipient screening allergy testing for individuals without history of a severe allergic reaction to the SARS-CoV-2 vaccine/excipient, and a shared decision-making paradigm in consultation with an allergy specialist for individuals with a history of a severe allergic reaction to the SARS-CoV-2 vaccine/excipient. We recommend further research to clarify SARS-CoV-2 vaccine/vaccine excipient testing utility in individuals potentially allergic to SARS-CoV2 vaccines or their excipients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaip.2021.06.006

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 204

Metadata

Authors
Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., Alqurashi, W., Arkwright, P., Baldwin, J. L., Ben-Shoshan, M., Bernstein, J., Bingemann, T., Blumchen, K., Byrne, A., Bognanni, A., Campbell, D., Campbell, R., Chagla, Z., Chan, E. S., Chan, J., Comberiati, P., Dribin, T. E., Ellis, A. K., Fleischer, D. M., Fox, A., Frischmeyer-Guerrerio, P. A., Gagnon, R., Grayson, M. H., Horner, C. C., Hourihane, J., Katelaris, C. H., Kim, H., Kelso, J. M., Lang, D., Ledford, D., Levin, M., Lieberman, J., Loh, R., Mack, D., Mazer, B., Mosnaim, G., Munblit, D., Mustafa, S. S., Nanda, A., Oppenheimer, J., Perrett, K. P., Ramsey, A., Rank, M., Robertson, K., Sheikh, J., Spergel, J. M., Stukus, D., Tang, M. L. K., Tracy, J. M., Turner, P. J., Whalen-Browne, A., Wallace, D., Wang, J., Waserman, S., Witry, J. K., Worm, M., Vander Leek, T. K., & Golden, D. B. K.
Venue
The Journal of Allergy and Clinical Immunology: In Practice
Publisher
Elsevier BV
Published
2021-10
Volume
9
Issue
10
Pages
3546-3567
ISSN
2213-2198 (ISSN-L)
OpenAlex
W3175982156
Cited by
204
References
28
FWCI
6.27
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. https://app.cochat.ai/papers/10.1016/j.jaip.2021.06.006
The paper
Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D., Akin, C., Alqurashi, W., Arkwright, P., Baldwin, J. L., Ben-Shoshan, M., Bernstein, J., Bingemann, T., Blumchen, K., Byrne, A., Bognanni, A., Campbell, D., Campbell, R., Chagla, Z., Chan, E. S., . . . Golden, D. B. K. (2021). The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2021.06.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.